Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pre-menopausal Breast Cancer × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1093 Triple Negative Breast Neoplasms 247 Ovarian Neoplasms 227 Carcinoma, Non-Small-Cell Lung 217 Colorectal Neoplasms 165 Pancreatic Neoplasms 155 Stomach Neoplasms 145 Neoplasms 140 Neoplasm Metastasis 138 Lung Neoplasms 130 Prostatic Neoplasms 126 Melanoma 115 Squamous Cell Carcinoma of Head and Neck 89 Carcinoma, Renal Cell 89 Endometrial Neoplasms 84 Head and Neck Neoplasms 79 Colonic Neoplasms 77 Urinary Bladder Neoplasms 70 Esophageal Neoplasms 67 Uterine Cervical Neoplasms 66 Breast Neoplasms, Male 64 Sarcoma 63 Small Cell Lung Carcinoma 58 Carcinoma, Ovarian Epithelial 54 Carcinoma, Hepatocellular 53 Kidney Neoplasms 43 Rectal Neoplasms 33 Carcinoma, Transitional Cell 31 Lymphoma, Non-Hodgkin 29 Fallopian Tube Neoplasms 29

Interventions

NVP-BKM120 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02058381 2020-03-09

B-YOND

Novartis

Phase 1 Completed

Pre-menopausal Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡